Drugmakers Dispute Scope of Orphan Drug Exclusivity By Sam | November 19, 2018 Drugmakers argued against broad orphan exclusivity for Eagle Pharmaceuticals’ Bendeka (bendamustine) in public comments to the FDA. Source: International Pharmaceutical Regulatory Monitor Posted in International Pharmaceutical Regulatory Monitor